US self-pay prices

Next Vial GLP-1 prices

Last updated

Compounding

Next Vial publishes no price we can compare: the same medicines at sellers we link to

  • Compounded semaglutide, not FDA-approved: lowest on a monthly plan at a seller we link to

    Collective

    $59/mo + $199/yr membership · about $76 a month over a year with the membership · first order: membership free for the first 21 days, never charged if you cancel before

  • Compounded tirzepatide, not FDA-approved: lowest at a seller we link to

    Collective

    $69/mo + $199/yr membership · about $86 a month over a year with the membership · first order: membership free for the first 21 days, never charged if you cancel before

Sellers we link to pay us if you buy, which never changes a price we show.

Online telehealth seller of compounded semaglutide and tirzepatide prescribed after an online consultation with a healthcare professional. Its pages state different starting prices and no price per medicine, so none is compared (from its own site, nextvial.com). Compounded; not FDA-approved. No current medication price is tracked for Next Vial right now; the dated records below show what it last published.

Trustpilot 4.0 (16 reviews)Is Next Vial legit?

0 current prices

Lowest maintenance 30-day cost · · 0 with a maintenance price

  • Compounded semaglutide

    Semaglutide · Compounded

    Not FDA-approved
    Check price

    No current cited price verified

    Top dose: No separate price on record

    Terms & source

    Advertised price: its GLP-1 page says "Doctor-Led Weight Loss Plans as Low as $249.97/Month" for both medicines, and its own page data gives a different starting figure, so we do not compare a price

    Its page says "This is a compounded medication and is not FDA-approved." Compounded; not FDA-approved.

    Confirm the prescribed dose, supply length, membership or consultation fees, and refill conditions with the seller. A listed offer does not confirm eligibility or stock.

    Advertised price as read on its own page (nextvial.com)
  • Compounded tirzepatide

    Tirzepatide · Compounded

    Not FDA-approved
    Check price

    No current cited price verified

    Top dose: No separate price on record

    Terms & source

    Advertised price: its GLP-1 page says "Doctor-Led Weight Loss Plans as Low as $249.97/Month" for both medicines, and its own page data gives a different starting figure, so we do not compare a price

    Its page says "This is a compounded medication and is not FDA-approved." Compounded; not FDA-approved.

    Confirm the prescribed dose, supply length, membership or consultation fees, and refill conditions with the seller. A listed offer does not confirm eligibility or stock.

    Advertised price as read on its own page (nextvial.com)

Read prices in context. Compare the same product, dose and payment terms; missing prices are not estimated. Compounded medicines are not FDA-approved.

How prices are compared, what FDA says about compounding

A prepaid monthly rate is not a monthly payment. Cost order uses current, recently checked quotes, converted to 30 days: by the supply a price buys where the seller states it in days, otherwise a monthly price with its plan length on record read as four weekly doses, a yearly membership in the price spread over twelve months. Introductory prices, ranges, prices with no plan length on record and separately billed fees are unranked references. Dose changes and added fees affect what you pay.

A listed maintenance dose is not a dosing recommendation.

FDA declared the tirzepatide (December 2024) and semaglutide (February 2025) shortages resolved (fda.gov/drugs/drug-alerts-and-statements/fda-clarifies-policies-compounders-national-glp-1-supply-begins-stabilize). Its conditions for a pharmacy compounding them now include "The drug product is compounded for an individual patient based on receipt of a prescription" and "The compounder does not compound, regularly or in inordinate amounts, any that are essentially copies of a commercially available drug product." (fda.gov/drugs/drug-alerts-and-statements/fda-clarifies-policies-compounders-national-glp-1-supply-begins-stabilize) In May 2026 FDA proposed leaving semaglutide, tirzepatide and liraglutide off the 503B Bulks List (federalregister.gov/documents/2026/05/01/2026-08552/list-of-bulk-drug-substances-for-which-there-is-a-clinical-need-under-section-503b-of-the-federal), the ingredients outsourcing facilities may compound from; comments closed Jul 30, 2026 (govinfo.gov/content/pkg/FR-2026-06-26/html/2026-12937.htm), and we found no final notice when we last read the Federal Register (Nov 6, 2026). FDA's newest warning letter to a pharmacy over compounded semaglutide or tirzepatide went to Empower Clinic Services, LLC dba Empower Pharmacy (fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/empower-clinic-services-llc-dba-empower-pharmacy-738238-09182026) on Sep 18, 2026 (every GLP-1 warning letter). FDA's newest recall report of a compounded semaglutide or tirzepatide product is Houston Rx LLC's tirzepatide (api.fda.gov/drug/enforcement.json), reported Oct 21, 2026: "Lack of assurance of sterility." (every tirzepatide recall). Liraglutide is different: FDA's shortage database (accessdata.fda.gov/scripts/drugshortages) still lists it in shortage (updated at source Oct 14, 2026; every GLP-1 shortage). FDA: "Compounded drugs are not FDA-approved. This means that FDA does not verify the safety, effectiveness or quality of compounded drugs before they are marketed." (fda.gov/drugs/human-drug-compounding/compounding-and-fda-questions-and-answers) A low price is not a low-risk signal; confirm current terms with the provider.

Seller pages re-read automatically : 1 of 1 opened and checked for price changes. How prices stay current

Updated automatically

Next Vial price changes

  • Seller recordNext Vial: new record on its public ratings and records
  • Seller recordNext Vial: updated record on its public ratings and records

Written from each source's own record as it changes. Every change on GLPcompare

Questions

Next Vial GLP-1 cost: common questions

How much does semaglutide cost through Next Vial?

Compounded semaglutide: its own pages state different prices for the same plan (its GLP-1 page says "Doctor-Led Weight Loss Plans as Low as $249.97/Month" for both medicines, and its own page data gives a different starting figure, so we do not compare a price). Checked Nov 13, 2026 on nextvial.com; each quote names its page in the table. Compounded semaglutide is not an FDA-approved product.

How much does tirzepatide cost through Next Vial?

Compounded tirzepatide: its own pages state different prices for the same plan (its GLP-1 page says "Doctor-Led Weight Loss Plans as Low as $249.97/Month" for both medicines, and its own page data gives a different starting figure, so we do not compare a price). Checked Nov 13, 2026 on nextvial.com; each quote names its page in the table. Compounded tirzepatide is not an FDA-approved product.

Is Next Vial FDA-approved? Does it sell FDA-approved GLP-1 medication or compounded versions?

The FDA approves medicines, not online sellers such as Next Vial. The Next Vial offers tracked here are compounded: Compounded semaglutide; Compounded tirzepatide. Compounded GLP-1s are not FDA-approved products and are not reviewed by the FDA for safety, effectiveness, or quality.

Which states does Next Vial serve?

Next Vial's own pages, read Nov 17, 2026, do not say which states it serves, so ask before you pay. Which GLP-1 sellers serve your state

How do I cancel Next Vial?

Next Vial's own pages, read Nov 17, 2026, do not say how to cancel. Ask Next Vial how to stop the plan and what notice it needs before you pay. How to cancel each GLP-1 seller, in its own words

Does Next Vial accept HSA or FSA?

Next Vial's own pages, read Nov 17, 2026, say nothing about paying with an HSA or FSA, so ask Next Vial before you count on it. The IRS rule, and the sellers whose own pages say they take it, are on the page below. GLP-1 with an HSA or FSA: the IRS rule and every seller

Does Next Vial take insurance?

Next Vial's own pages, read Nov 17, 2026, say nothing about insurance, so plan on paying yourself unless Next Vial tells you otherwise. Whether your plan covers a medication is your plan's answer. Which online GLP-1 programs take insurance: every seller

When were Next Vial prices last checked?

Each quote carries its own check date and names the page it was read from: Nov 13, 2026 for the offers here. A quote not rechecked within 21 days is kept as a dated reference and is no longer stated as a current price.

Is Next Vial legit?

Next Vial is an operating online seller that scores 4.0 out of 5 on Trustpilot from 16 reviews. The BBB's search shows no health business named Next Vial (read Nov 14, 2026). We found no FDA warning letter naming Next Vial as of Nov 15, 2026. These records describe how a business deals with customers and what regulators have told it; they do not measure medical quality or results. Is Next Vial legit? Every record, with its source

Does Next Vial have a Black Friday sale or promo code?

We found no promo code or sale on Next Vial's homepage when we read it on Nov 16, 2026. A sale can appear after that, and some sellers apply one only at checkout. We do not list codes from coupon sites, because we cannot confirm them. Every GLP-1 sale and promo code we can verify

Can I use my own pharmacy with Next Vial?

Yes, by its own terms. Next Vial's words: "While there may be a preferred pharmacy used, patient has the ability to direct their prescription to any pharmacy of their choosing." (nextvial.com/terms, read Nov 14, 2026).

Are you Next Vial? See how sellers are listed, how to correct a price and how to set up a referral link with us.

GLPcompare is an informational data platform, not a medical provider or pharmacy. Nothing here is medical advice, a diagnosis, or a recommendation to start, stop, or change any treatment. Data is aggregated from public sources and can be incomplete or out of date. Always confirm with a licensed clinician and the current FDA label.